BTT Groups

4:45 PM - 5:00 PM (PDT), Monday, June 13, 2022
BTT Groups, head-quartered in Korea, are the global non-clinical service providers composed of Biotoxtech and its subsidiary Keyfronbio and Keyprime Research.
Biotoxtech has expertise in non-clinical tox study and can provides all IND and NDA enabling tox studies. It has submitted hundreds of documents to the regulatory agencies of US, Japan and Europe. It has Full AAALAC Accreditation and is the only domestic private CRO to receive GLP accreditation from the US FDA.
Keyfronbio is specialized in non-clinical pharmacology including efficacy study, PCR-based bio-distribution study for CGTs, and GLP-compliant bioanalysis. Keyprime Research offers NHP-based Tox and efficacy studies with high expertise in non-clinical studies for various types of biologics., and also provides rodent/NHP inhalation toxicology study.
The collaboration of BTT Groups synergistically offers a comprehensive and integrated platform of non-clinical services bringing candidate molecules to early phase and NDA.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2000
Main Therapeutic Focus:
Lead Product in Development:
BTT-0811, BTT-105
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Director
Biotoxtech